Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
View Patent ↗The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
1. A compound of the general formula:
wherein X and X′ are independently O or S;
A is unsubstituted or substituted phenyl wherein the substituents are independently 1 to 5H; halo; nitro; cyano; hydroxy; amino (—NR a R b ); alkylaminolkyl (—(CH 2 ) n NR a R b ); (C 1 -C 6 )alkyl; (C 1 -C 6 )haloalkyl; (C 1 -C 6 )cyanoalkyl; (C 1 -C 6 )hydroxyalkyl; (C 1 -C 6 )alkoxy; phenoxy; (C 1 -C 6 )haloalkoxy; (C 1 -C 6 )alkoxy(C 1 -C 6 )alkyl; (C 1 -C 6 )alkenyloxy(C 1 -C 6 )alkyl; (C 1 -C 6 )alkoxy(C 1 -C 6 )alkoxy; (C 1 -C 6 )alkanoyloxy(C 1 -C 6 )alkyl; (C 2 -C 6 )alkenyl optionally substituted with halo, cyano, (C 1 -C 4 )alkyl, or (C 1 -C 4 )alkoxy; (C 2 -C 6 )alkynyl optionally substituted with halo or (C 1 -C 4 )alkyl; formyl; carboxy; (C 1 -C 6 )alkylcarbonyl; (C 1 -C 6 )haloalkylcarbonyl; benzoyl; (C 1 -C 6 )alkoxycarbonyl; (C 1 -C 6 )haloalkoxycarbonyl; (C 1 -C 6 )alkanoyloxy (—OCOR a ); carboxamido (—CONR a R b ); amido (—NR a COR b ); alkoxycarbonylamino (—NR a CO 2 R b ); alkylaminocarbonylamino (—NR a CONR b R c ); mercapto; (C 1 -C 6 )alkylthio; (C 1 -C 6 ) alkylsulfonyl; (C 1 -C 6 )alkylsulfonyl(C 1 -C 6 )alkyl; (C 1 -C 6 )alkylsulfoxido (—S(O)R a ); (C 1 -C 6 )alkylsulfoxido(C 1 -C 6 )alkyl —(CH 2 ) n S(O)R a ); sulfamido (—SO 2 NR a R b ); —SO 3 H; or unsubstituted or substituted phenyl wherein the substituents are independently 1 to 3 halo, nitro, (C 1 -C 6 ) alkoxy, (C 1 -C 6 )alkyl, or amino; or when one or both of two adjacent positions on the phenyl ring are substituted, the attached atoms may form the phenyl-connecting termini of a linkage selected from the group consisting of (—OCH 2 O—), (—OCH(CH 3 )O—), (—OCH 2 CH 2 O—), (—OCH(CH 3 )CH 2 O—), (—S—CH═N—), (—CH 2 OCH 2 O—), (—O(CH 2 ) 3 —), (═N—O—N═), (—CH═CH—NH—), (—OCF 2 O—), (—NH—CH═N—), (—CH 2 CH 2 O—), and (—(CH 2 ) 4 —);
B is
(a) unsubstituted or substituted phenyl wherein the substituents are independently 1 to 5H; halo; nitro; cyano; hydroxy; amino (—NR a R b ); alkylaminolkyl (—(CH 2 ) n NR a R b ); (C 1 -C 6 )alkyl; (C 1 -C 6 )haloalkyl; (C 1 -C 6 )cyanoalkyl; (C 1 -C 6 )hydroxyalkyl; (C 1 -C 6 )alkoxy; phenoxy; (C 1 -C 6 )haloalkoxy; (C 1 -C 6 )alkoxy(C 1 -C 6 )alkyl; (C 1 -C 6 )alkenyloxy(C 1 -C 6 )alkyl; (C 1 -C 6 )alkoxy(C 1 -C 6 )alkoxy; (C 1 -C 6 )alkanoyloxy(C 1 -C 6 )alkyl; (C 2 -C 6 )alkenyl optionally substituted with halo, cyano, (C 1 -C 4 ) alkyl, or (C 1 -C 4 )alkoxy; (C 2 -C 6 )alkynyl optionally substituted with halo or (C 1 -C 4 )alkyl; formyl; carboxy; (C 1 -C 6 )alkylcarbonyl; (C 1 -C 6 )haloalkylcarbonyl; benzoyl; (C 1 -C 6 )alkoxycarbonyl; (C 1 -C 6 )haloalkoxycarbonyl; (C 1 -C 6 )alkanoyloxy (—OCOR a ); carboxamido (—CONR a R b ); amido (—NR a COR b ); alkoxycarbonylamino (—NR a CO 2 R b ); alkylaminocarbonylamino (—NR a CONR b R e ); mercapto; (C 1 -C 6 )alkylthio; (C 1 -C 6 ) alkylsulfonyl; (C 1 -C 6 )alkylsulfonyl(C 1 -C 6 )alkyl; (C 1 -C 6 )alkylsulfoxido (—S(O)R a ); (C 1 -C 6 )alkylsulfoxido(C 1 -C 6 )alkyl (—CH 2 ) n S(O)R a ); sulfamido (—SO 2 NR a R b ); —SO 3 H; —CH═N—NHC(O)NR a R b ; —CH═N—NHC(O)C(O)NR a R b ; or unsubstituted or substituted phenyl wherein the substituents are independently 1 to 3 halo, nitro, (C 1 -C 6 ) alkoxy, (C 1 -C 6 )alkyl, or amino; or when one or both of two adjacent positions on the phenyl ring are substituted, the attached atoms may form the phenyl-connecting termini of a linkage selected from the group consisting of (—OCH 2 O—), (—OCH(CH 3 )O—), (—OCH 2 CH 2 O—), (—OCH(CH 3 )CH 2 O—), (—S—CH═N—), (—CH 2 OCH 2 O—), (—O(CH 2 ) 3 —), (═N—O—N═), (—CH═CH—NH—), (—OCF 2 O—), (—NH—CH═N—), (—CH 2 CH 2 O—), and (—(CH 2 ) 4 —);
(b) unsubstituted 6-membered heterocycle or substituted 6-membered heterocycle having 1-3 nitrogen atoms and 3-5 nuclear carbon atoms where the substituents are from one to three of the same or different halo; nitro; hydroxy; (C 1 -C 6 )alkyl; (C 1 -C 6 )alkoxy; (C 1 -C 6 )thioalkoxy; carboxy; (C 1 -C 6 )alkoxycarbonyl; (C 1 -C 6 )carboxyalkyl; (C 1 -C 6 )alkoxycarbonylalkyl having independently the stated number of carbon atoms in each alkyl group; —CONR a R b ; amino; (C 1 -C 6 )alkylamino; (C 1 -C 6 )dialkylamino having independently the stated number of carbon atoms in each alkyl group; haloalkyl; —CH═N—NHC(O)NR a R b ; or —CH═N—NHC(O)C(O)NR a R b ; or
(c) 5-benzimidazolyl; 1-trityl-5-benzimidazolyl; 3-trityl-5-benzimidazolyl; 1H-indazole-3-yl; 1-trityl-1H-indazole-3-yl; or 1-(C 1 -C 6 )alkyl-1H-indole-2-yl;
E is unsubstituted or substituted (C 4 -C 10 ) branched alkyl wherein the substituents are independently 1-4 cyano; halo; (C 5 -C 6 )cycloalkyl; phenyl; (C 2 -C 3 )alkenyl; hydroxy, (C 1 -C 6 )alkoxy; carboxy; (C 1 -C 6 )alkoxycarbonyl; formyl; (C 1 -C 6 )trialkylsilyloxy having independently the stated number of carbon atoms in each alkyl group; —CH═N—OR a ; —CH═N—R d ; —CH═N—NHC(O)NR a R b ; or —CH═N—NHC(O)C(O)NR a R b ;
wherein R a , R b , and R c are independently H, (C 1 -C 6 )alkyl, or phenyl; R d is hydroxy(C 1 -C 6 )alkyl; and n=1-4; and
G is H or CN;
provided that:
1) when E is unsubstituted or substituted (C 4 -C 10 ) branched alkyl wherein the substituents are independently 1-4 cyano; halo; (C 2 -C 3 )alkenyl; carboxy; or (C 1 -C 6 )alkoxycarbonyl;
then B is:
(a) substituted phenyl which bears at least one —CH═N—NHC(O)NR a R b or —CH═N—NHC(O)C(O)NR a R b group;
(b) substituted 6-membered heterocycle having 1-3 nitrogen atoms and 3-5 nuclear carbon atoms which bears at least one haloalkyl group; or
(c) 5-benzimidazolyl; 1-trityl-5-benzimidazolyl; 3-trityl-5-benzimidazolyl; 1H-indazole-3-yl; 1-trityl-1H-indazole-3-yl; or 1-(C 1 -C 6 )alkyl-1H-indole-2-yl;
wherein R a , R b are independently H, (C 1 -C 6 )alkyl, or phenyl; or
2) when E is a substituted (C 4 -C 10 ) branched alkyl which bears at least one of phenyl; hydroxy, (C 1 -C 6 )alkoxy; or formyl;
then B is:
(a) substituted phenyl which bears at least one —CH═N—NHC(O)NR a R b or —CH═N—NHC(O)C(O)NR a R b group;
(b) substituted or unsubstituted 6-membered heterocycle having 1-3 nitrogen atoms and 3-5 nuclear carbon atoms; or
(c) 5-benzimidazolyl; 1-trityl-5-benzimidazolyl; 3-trityl-5-benzimidazolyl; 1H-indazole-3-yl; 1-trityl-1H-indazole-3-yl; or 1-(C 1 -C 6 )alkyl-1H-indole-2-yl;
wherein R a and R b are independently H, (C 1 -C 6 )alkyl, or phenyl.
2. The compound of claim 1 , wherein X and X′ are O and G is H.
3. The compound of claim 1 , wherein B is substituted 6-membered heterocycle having 1-3 nitrogen atoms and 3-5 nuclear carbon atoms where the substituents are from one to three of the same or different halo; nitro; hydroxy; (C 1 -C 6 )alkyl; (C 1 -C 6 )alkoxy; (C 1 -C 6 )thioalkoxy; carboxy; (C 1 -C 6 )alkoxycarbonyl; (C 1 -C 6 )carboxyalkyl; (C 1 -C 6 )alkoxycarbonylalkyl having independently the stated number of carbon atoms in each alkyl group; —CONR a R b ; amino; (C 1 -C 6 )alkylamino; (C 1 -C 6 )dialkylamino having independently the stated number of carbon atoms in each alkyl group; —CH═N—NHC(O)NR a R b ; —CH═N—NHC(O)C(O)NR a R b ; or —CF 3 .